Week In Review: CanSino Nears $1 Billion Valuation Following Hong Kong IPO
March 30, 2019 at 17:05 PM EDT
CanSino Biologics, a Tianjin vaccine company, rose 58% in its first trading day on the Hong Kong Exchange after staging its $161 million IPO. At the IPO price, CanSino was valued at $617 million; its market capitalization is now $968 million.
